Categorized | Melanoma In The News

Bacteria Composition May Determine Melanoma Patients’ Response to Anti-PD-1 Immunotherapy

Source: Melanoma News Today, February 2017

The presence of a specific bacteria in the gut of patients with melanoma, as well as a greater diversity of gut bacteria, are associated with a better response to anti-PD-1 immunotherapy.

Understanding this relationship between a patient’s gut bacteria profile and the immune system response could promote new cancer prognosis and treatment strategies.

These findings were presented at the 2017 ASCO-SITC Clinical Immuno-Oncology Symposium, held Feb. 23-25 in Orlando, Fla. The presentation was titled “Association of diversity and composition of the gut microbiome with differential responses to PD-1 based therapy in patients with metastatic melanoma.”

read the original full article

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories